Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4901–4950 of 18416
Additionally, effective June 3, 2024, the Board of Directors of the Company appointed Matthew Sallee to succeed Courtney Gengler as Chief Executive Officer of the Company, effective as of the close of business on June 7, 2024.
Ms. Gengler, who is leaving Tortoise Capital Advisors, L.L.C. (the “ Adviser ”) to pursue other opportunities effective as of the close of business on June 7, 2024.
effective June 3, 2024, the Board of Directors of the Company appointed Matthew Sallee to succeed Courtney Gengler as Chief Executive Officer of the Company, effective as of the close of business on June 7, 2024.
On June 3, 2024, the Company announced the appointment of James R. Anderson as CEO of the Company, effective June 3, 2024
In compliance with his CEO Succession and Retirement Agreement dated February 17, 2024, Dr. Mattera resigned as a Class One member of the Board immediately before the Start Date
On May 31, 2024, the Company appointed Elizabeth Rafael as Interim Chief Financial Officer, effective as of May 31, 2024.
Raymond E. Reitsma has resigned as Executive Vice President (“EVP”) and Chief Operating Officer (“COO”) of Mercantile, and has been appointed as President and CEO of Mercantile and CEO of the Bank.
Robert B. Kaminski, Jr. has retired as President and Chief Executive Officer (“CEO”) of Mercantile and as CEO of Mercantile’s wholly owned subsidiary, Mercantile Bank (the “Bank”).
The appointment follows the resignation of James Anderson on May 31, 2024, from his position as President, Chief Executive Officer, and member of the Board to pursue an opportunity with another company, effective as of June 3, 2024.
On June 3, 2024, Lattice Semiconductor Corporation (the “Company”) announced that on May 31, 2024, the Board of Directors of the Company (the “Board”) appointed Esam Elashmawi, Chief Marketing and Strategy Officer, as Interim Chief Executive Officer in addition to his existing position at the Company and designated Mr. Elashmawi as the Company’s principal executive officer, effective June 3, 2024.
On May 29, 2024, Judith S. Miller was terminated as Interim Chief Financial Officer and Chief Business Officer of the Company.
On May 29, 2024, the Company appointed Brian J. McMenamy, our Vice President, Controller, to the position of Vice President and Interim Chief Financial Officer and designated him Principal Financial Officer, effective as of the close of business on June 14, 2024.
On May 29, 2024, Scott M. Haralson notified Spirit Airlines, Inc. (the “Company”) of his resignation as Executive Vice President and Chief Financial Officer of the Company, effective as of the close of business on June 14, 2024, in order to pursue another opportunity.
the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.
Effective June 1, 2024, our board of directors appointed Ian T. Bothwell, the Company’s Chief Financial Officer to serve in the additional position of Interim Chief Executive Officer
On May 30, 2024, Mark Conley, 62, was appointed Interim Chief Financial Officer of SAB Biotherapeutics, Inc., a Delaware corporation (the “Company”), effective June 4, 2024.
On May 26, 2024, Michael King, Jr., Chief Financial Officer of the Company, informed the Company that he will resign from his position with the Company, effective June 4, 2024, to pursue another opportunity.
On May 31, 2024, PetMed Express, Inc. (the “Company”) entered into a Transition and Separation Agreement (the “Agreement”) with Christine Chambers, the Company’s Chief Financial Officer, Treasurer, and Secretary, pursuant to which the Company and Ms. Chambers agreed to the mutual termination of Ms. Chambers’ employment with the Company following a transition period.
On May 29, 2024, the Board determined that David N. Makuen would transition from the role of Chief Executive Officer, effective June 1, 2024.
appointed Kenneth D. Seipel, a current member of the Board, to the position of Interim Chief Executive Officer, effective as of June 2, 2024.
Effective May 30, 2024, William Duke, Jr., the Company’s Chief Financial Officer, will serve as the Company’s “principal executive officer”.
Jeremy Gowler, the Interim Chief Executive Officer, Chief Operating Officer and Chief Commercial Officer of Invivyd, Inc. (the “Company”), ceased serving as an executive officer and as the Company’s “principal executive officer,” effective as of May 30, 2024, with his employment terminating on June 29, 2024.
On May 29, 2024, for personal reasons, Christopher G. Thomas resigned from his position as Co-Chief Executive Officer of the Company, effective immediately.
the employment of Douglas Godshall, the Company’s President and Chief Executive Officer, and Renee Gaeta, the Company’s Chief Financial Officer, was terminated effective immediately prior to the consummation of the Merger.
the employment of Douglas Godshall, the Company’s President and Chief Executive Officer, and Renee Gaeta, the Company’s Chief Financial Officer, was terminated effective immediately prior to the consummation of the Merger.
On May 31, 2024, the board of directors of the Company appointed Mr. Michael Minnick as CEO of the Company, effective immediately.
On May 31, 2024, Shmuel Chafets informed Target Global Acquisition I Corp. (the “Company”) of his decision to resign as Chief Executive Officer (“CEO”) of the Company, effective immediately.
The Company’s board of directors intends to appoint J. Scott Wolchko, the Company’s President and Chief Executive Officer, to succeed Mr. Dulac as the Company’s Chief Financial Officer and also serve as the Company’s principal financial and accounting officer, effective immediately after Mr. Dulac’s resignation.
On May 30, 2024, Edward J. Dulac III provided notice of his resignation from his position as Chief Financial Officer of Fate Therapeutics, Inc. (the “Company”), which will be effective June 14, 2024.
On May 31, 2024, Anthony R. Corpora stepped down as the chief executive officer and a board member of US Lighting Group, Inc.
On May 29, 2024, Philip R. Mays, age 56, was appointed Senior Vice President, Chief Financial Officer and Treasurer of CTO Realty Growth, Inc. (the “Company”), effective as of June 17, 2024.
Mr. Paul Lytle, EVP, Chief Financial Officer of the Company, agreed to amend Mr. Lytle’s employment terms from full time status to part time status, not to exceed eight (8) hours per month effective June 1, 2024
announced that it has appointed Jennifer Gerold as the Company’s Chief Financial Officer
Ms. Gerold replaces Steven Gargano who served the Company as CFO since 2020.
The Company expects to name Mr. André as Chief Financial Officer on or about August 5, 2024.
Mr. Larson will step down from the role of Chief Financial Officer effective on or about August 5, 2024
following Ms. Marina Wolfson’s return from maternity leave
Effective May 31, 2024, Mr. Avraham Gabay’s term as Interim Chief Financial Officer of the Company will conclude
John Dolan, age 56, who has served as the Company’s senior vice president, chief accounting officer since May 2022, will succeed Mr. Stelben as the Company’s senior vice president, chief financial officer, effective August 31, 2024.
On May 29, 2024, John Stelben notified eHealth, Inc. (the “Company”) of his decision to resign from his position as the Company’s senior vice president, chief financial officer, effective August 30, 2024.
Zachary B. Fleming tendered his resignation as the Chief Executive Officer of Sanara MedTech Inc. (the “Company”), effective as of such date
Beth Boulerice will step down from her roles as Chief Financial Officer and Treasurer effective March 1, 2025.
Mr. Brunner will be appointed to succeed Ms. Boulerice as Chief Financial Officer and Treasurer effective March 1, 2025.
On May 23, 2024, Mr. Kevin Schubert and the Company entered into a General Release and Separation Agreement (the “Separation Agreement”) wherein Mr. Schubert resigned from his role as Chief Financial Officer of Rubicon Technologies, Inc. (the “Company”), effective June 1, 2024.
On May 23, 2024, the Company entered into an amendment to that certain Offer Letter Agreement (the “Amendment”) entered into between the Company and Mr. Grant Deans dated August 29, 2023, wherein the Company offered Mr. Deans the position of Interim Chief Financial Officer.
appointed Adarsh Parekh as the Company’s Chief Financial Officer and Executive Vice President, effective as of June 17, 2024
appointed Brendan P. O’Grady to serve as the Company’s Chief Executive Officer (and principal executive officer) and as a director.
As previously reported, Ms. Wadsten communicated her intention to the Company to retire as of June 3, 2024.
On May 23, 2024, the Board of Directors of Jackson Financial Inc. (the “Company”) appointed Don W. Cummings as the Company’s new Executive Vice President and Chief Financial Officer (“CFO”) beginning June 3, 2024.
On May 23, 2024, Photronics, Inc. (the “Company”) named Eric Rivera Chief Financial Officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.